Hosokawa, Susumu <br/><br/>
Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.  [electronic resource] 

 -  Cardiovascular research  Jul 2013 
 - 35-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-3245 
<br/><br/><label>Standard No.: </label>10.1093/cvr/cvt105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzamides--pharmacology<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Chemokine CCL2--metabolism<br/>Disease Models, Animal<br/>Familial Primary Pulmonary Hypertension<br/>Feedback, Physiological<br/>Fibroblast Growth Factor 2--genetics<br/>Hypertension, Pulmonary--chemically induced<br/>Male<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Monocrotaline<br/>Muscle, Smooth, Vascular--drug effects<br/>Myocytes, Smooth Muscle--drug effects<br/>NF-kappa B--antagonists & inhibitors<br/>Pulmonary Artery--drug effects<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Tissue Plasminogen Activator--genetics<br/>Transcription Factor RelA--antagonists & inhibitors<br/>Ventricular Function, Right--drug effects<br/>Ventricular Pressure--drug effects